Phase II seizure data on UX-007 in patients with glucose transporter type-1 deficiency syndrome March 23, 2017
Fixed-dose combination tablets containing ertugliflozin show promise for type 2 diabetes March 23, 2017
Arix Bioscience signs collaboration agreements to develop therapeutics for metabolic diseases March 22, 2017
RSS